GE/G-Con aim for modular, mobile vax making

GE Healthcare and G-Con Manufacturing say they will collaborate on a portable bio-process manufacturing solution for vaccines. GE brings biopharma technology and a global presence; G-Con, its modular cleanroom technology.

GE says in a statement the deal moves it closer to its "vision of modular and possibly mobile flexible biopharmaceutical manufacturing facilities--the vaccine factory in a box."

Disposables-based vaccine manufacturing is a fast-moving technology space, and the GE/G-Con play faces worthy adversaries.

G-Con knows this, based on its participation in DARPA's Blue Angel initiative to demonstrate quickened vaccine production through a process involving tobacco plants. Fraunhofer USA and Medicago are also Blue Angel participants.

And Xcellerex will be another competitor. The disposable platform provider announced rapid swine flu production in a test last May with Pfenex and collaborators.

- see the G-Con release

Suggested Articles

Lonza CEO Marc Funk is leaving for "personal reasons" after less than a year in the top job. 

Drugmakers have voluntarily recalled their generic Zantac from the U.S. market after the FDA raised concerns, but it has not been without a cost.

Just weeks after selling the sterile manufacturing assets of its Kyowa operation in Japan, it has unloaded the rest of its Kyowa drugmaking operation.